Altered cytokine levels in pediatric ITP.
Göteborg, Sweden. In Platelets, 25 Apr 2015
Plasma levels of chemokine (C-X3-C motif) ligand 1 (CX3CL1), transforming growth factor β1 (TGF-β1), and interleukin 22 (IL-22) were analyzed in both cohorts using enzyme-linked immunosorbent assays (ELISAs).
Novel therapeutic targets in rheumatoid arthritis.
Nijmegen, Netherlands. In Trends Pharmacol Sci, 27 Mar 2015
Here, we discuss two pathways that are regarded as interesting novel therapeutic targets in the field of rheumatology: the Janus kinase (JAK) pathway and the T helper-17 (Th17) pathway [including interleukin (IL)-17, IL-21, IL-22, and granulocyte-macrophage colony-stimulating factor (GM-CSF)].
Interleukin-22: Immunobiology and Pathology.
Melbourne, Australia. In Annu Rev Immunol, 11 Mar 2015
UNASSIGNED: Interleukin-22 (IL-22) is a recently described IL-10 family cytokine that is produced by T helper (Th) 17 cells, γδ T cells, NKT cells, and newly described innate lymphoid cells (ILCs).
Memory T follicular helper CD4 T cells.
Atlanta, United States. In Front Immunol, Dec 2014
This specialized T helper subset provides help to cognate B cells via their expression of CD40 ligand, IL-21, IL-4, and other molecules.
Inflammation versus host defense in obesity.
Houston, United States. In Cell Metab, Dec 2014
(2014) report that immune cells from obese mice have decreased production of IL-22, a cytokine involved in immune responses and inflammation, and reveal therapeutic effects of exogenous IL-22 against obesity-linked metabolic dysfunctions.